In a significant judgment handed down in respect of Amgen’s European Patent EP3666797, which is a member of a patent…

Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…

A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…

A recent EPO Board of Appeal (BoA) decision (T 1553/22) considered the patentability of human-animal chimeras (organisms or tissues that…

Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….

Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…

Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple…

The use of AI has revolutionised the speed and accuracy of diagnosis for a host of conditions including breast cancer,…

Clinical trials are an expensive and risky business. The investment of time, resources and costs grows with progression through the…

The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…

Surgery is, by its very nature, an invasive procedure. It can be transformative to the quality of life of those…

With so many of 2020’s headlines focussed on Covid and Brexit we can be forgiven for letting an important anniversary…